NOD Pharmaceuticals

NOD Pharmaceuticals is a clinical-stage biotechnology company specializing in the development of oral delivery systems for macromolecular drugs, such as proteins and peptides, which are traditionally administered via injection. The company's proprietary NOD (Nano-Oral Delivery) platform utilizes nanotechnology to protect sensitive biologics from degradation in the gastrointestinal tract and enhance their absorption into the bloodstream. Their lead programs focus on metabolic diseases and bone health, including oral formulations of GLP-1 receptor agonists and parathyroid hormone. By transforming injectable therapies into convenient oral dosages, NOD Pharmaceuticals aims to improve patient compliance and therapeutic outcomes in chronic disease management.